Analysis of PTAP duplications in the gag p6 region of subtype C HIV type 1

AIDS Research and Human Retroviruses

Volumn 21, Issue 8, 2005, Pages 739-741

  Flys, Tamara ^a   Marlowe, Natalia ^b   Hackett Jr , John ^c   Parkin, Neil ^d   Schumaker, Michael ^b   Holzmayer, Vera ^c   Hay, Philip ^e   Eshleman, Susan H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CELERA   (United States)

^c ABBOTT LABORATORIES   (United States)

^d MONOGRAM BIOSCIENCES   (United States)

^e ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; GAG PROTEIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

AMINO ACID SEQUENCE; CLINICAL ARTICLE; DRUG RESPONSE; DRUG SENSITIVITY; GENE DUPLICATION; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SELECTION; GEOGRAPHIC DISTRIBUTION; GROUP SPECIFIC ANTIGEN GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

BASE SEQUENCE; GENE DUPLICATION; GENES, GAG; HIV-1; MOLECULAR SEQUENCE DATA;

EID: 24344487683     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.739     Document Type: Letter

References (6)

1. Marlowe N, Flys T, Hackett J, Schumaker M, Jackson JB, and Eshleman SH: Analysis of insertions and deletions in the gag p6 region of diverse HIV-1 strains. AIDS Res Hum Retroviruses 2004;20: 1119-1125.
2. Lastere S, Dalban C, Collin G, Descamps D, Girard PM, Clavel F, Costagliola D, and Brun-Vezinet F: Impact of amino acid insertions in HIV-1 p6 PTAP region on the virological response to amprenavir in the NARVAL trial. 10th Conferences on Retroviruses and Opportunistic Infections, Boston, MA, 2003.
3. Peters S, Munoz M, Yerly S, Sanchez-Merino V, Lopez-Galindez C, Perrin L, Larder B, Cmarko D, Fakan S, Meylan P, and Telenti A: Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol, 2000;75:9644-9653.
4. Petropoulos CJ, Parkin NT, Limoli KL, Lie YS, Wrin T, Huang W, Tian H, Smith D, Winslow GA, Capon DJ, and Whitcomb JM: A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother 2000;44: 920-928.
5. Campbell TB, Schneider K, Wrin T, Petropoulos CJ, and Connick E: Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma. J Virol 2003;77: 12105-12112.
6. Parkin NT, Hellmann NS, Whitcomb JM, Kiss L, Chappey C, and Petropoulos CJ: Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Antimicrob Agents Chemother 2004;48:437-443.